WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Ownership - Who owns Amicus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amicus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bradley L. CampbellPresident and CEO2025-03-1513,375$8.90
$119.04kSell
Bradley L. CampbellPresident and CEO2025-02-19400$10.00
$4.00kSell
Bradley L. CampbellPresident and CEO2025-02-19400$9.03
$3.61kBuy
Samantha ProutChief Accounting Officer2025-02-1113,500$9.57
$129.20kSell
Bradley L. CampbellPresident and CEO2025-02-1170,711$9.57
$676.70kSell
David Michael ClarkChief People Officer2025-02-1120,593$9.57
$197.08kSell
Ellen RosenbergChief Legal Officer2025-02-1128,584$9.57
$273.55kSell
Jeff CastelliChief Development Officer2025-02-1122,724$9.57
$217.47kSell
David Michael ClarkChief People Officer2025-01-042,692$9.41
$25.33kSell
Jeff CastelliChief Development Officer2025-01-043,127$9.41
$29.43kSell

1 of 5

FOLD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FOLD insiders and whales buy or sell their stock.

FOLD Shareholders

What type of owners hold Amicus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC12.33%37,018,271$252.83MInsider
Vanguard Group Inc9.75%29,258,963$199.84MInstitution
Wellington Management Group LLP9.48%28,461,994$194.40MInstitution
Blackrock Inc9.30%27,907,545$190.61MInstitution
Perceptive Advisors LLC8.08%24,245,952$165.60MInstitution
Avoro Capital Advisors LLC7.72%23,175,000$158.29MInstitution
William Blair Investment Management LLC5.20%15,597,698$106.53MInstitution
Redmile Group LLC4.30%12,890,146$88.04MInsider
Mark W. Perry3.66%10,982,416$75.01MInsider
Charles W. Newhall Iii3.66%10,982,416$75.01MInsider

1 of 3

FOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FOLD65.48%34.52%Net SellingNet Selling
MTSR0.00%67.20%Net BuyingNet Buying
VCEL91.07%8.93%Net SellingNet Selling
LGND16.60%83.40%Net SellingNet Selling
BHVN82.85%17.15%Net BuyingNet Buying
View Top Biotech Stocks

Amicus Therapeutics Stock Ownership FAQ

Who owns Amicus Therapeutics?

Amicus Therapeutics (NASDAQ: FOLD) is owned by 101.64% institutional shareholders, 53.59% Amicus Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Amicus Therapeutics shareholder, owning 37.02M shares representing 12.33% of the company. Perceptive Advisors LLC's Amicus Therapeutics shares are currently valued at $252.83M.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.